3 January 2022
Targeting NASH Drug Development with a New Humanized Liver NASH Model
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries, with an estimated incidence of around 25% worldwide.

We are revolutionizing the translational potential of animal models in preclinical research. Discover the latest articles and news about our recent activities.
3 January 2022
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries, with an estimated incidence of around 25% worldwide.
1 February 2021
Rare Disease Day takes place on the last day of February each year since 2008. The main objective of Rare Disease Day is to raise awareness about rare diseases and the impact they have on lives.